Development of interstitial pneumonia during treatment with eribulin: a case report

BACKGROUND: Eribulin is typically used to treat patients with advanced breast cancer, and anti-cancer agents often cause the development of interstitial pneumonia in Japanese patients with advanced cancer. However, few case reports have addressed eribulin-induced interstitial pneumonia. Herein, we r...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakamura, Kota, Kato, Motoyasu, Miyashita, Yosuke, Nagashima, Osamu, Sasaki, Shinichi, Tominaga, Shigeru, Takahashi, Kazuhisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5674230/
https://www.ncbi.nlm.nih.gov/pubmed/29110735
http://dx.doi.org/10.1186/s13104-017-2882-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5674230/
https://www.ncbi.nlm.nih.gov/pubmed/29110735
http://dx.doi.org/10.1186/s13104-017-2882-4

Ejemplares similares